People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Locus Biosciences, Inc. | — | Biotechnology | Series B | $46.3M | $213.3M | 2016 |
PAUL GAROFOLO at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside PAUL GAROFOLO on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Johnston | 1 | 8 |
| Stuart Peterson | 1 | 7 |
| NICK TAYLOR | 1 | 4 |
| GEOFFREY GLASS | 1 | 2 |
| Joseph Nixon | 1 | 1 |
| CHUCK BRAMLAGE | 1 | 1 |
| BARY BAILEY | 1 | 1 |
| David Ousterout | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.